Abstract
Intracerebronventricular (i.c.v.) injection of γ-mangostin (10–40 nmol/mouse), a major compound of the fruit hull of Garcinia mangostana Lin., like ketanserin (10, 20 nmol/mouse, i.c.v.) inhibited 5-fluoro-α-methyltryptamine (5-FMT) (45 mg kg−1, i.p.)-induced head-twitch response in mice in the presence or absence of citalopram (a 5-hydroxytryptamine (5-HT)-uptake inhibitor).
Neither the 5-FMT- nor the 8-hydroxy-2-(di-n-propylamino)tetralin (5-HT1A-agonist)-induced 5-HT syndrome (head weaving and hindlimb abduction) was affected by γ-mangostin or ketanserin.
The locomotor activity stimulated by 5-FMT through the activation of α1-adrenoceptors did not alter in the presence of γ-mangostin.
5-HT-induced inositol phosphates accumulation in mouse brain slices was abolished by ketanserin. γ-Mangostin caused a concentration-dependent inhibition of the inositol phosphates accumulation.
γ-Mangostin caused a concentration-dependent inhibition of the binding of [3H]-spiperone, a specific 5-HT2A receptor antagonist, to mouse brain membranes.
Kinetic analysis of the [3H]-spiperone binding revealed that γ-mangostin increased the Kd value without affecting the Bmax value, indicating the mode of the competitive nature of the inhibition by γ-mangostin.
These results suggest that γ-mangostin inhibits 5-FMT-induced head-twitch response in mice by blocking 5-HT2A receptors not by blocking the release of 5-HT from the central neurone. γ-Mangostin is a promising 5-HT2A receptor antagonist in the central nervous system.
Keywords: γ-Mangostin, 5-HT2 receptor antagonist, behavioural pharmacology, head-twitch response, 5-FMT, mouse brain
Full Text
The Full Text of this article is available as a PDF (462.4 KB).